The largest database of trusted experimental protocols

Skyra vd13

Manufactured by Siemens
Sourced in Germany

The Skyra VD13 is a high-performance laboratory equipment designed for versatile applications. It features a compact and durable construction, providing reliable performance in a wide range of laboratory settings. The core function of the Skyra VD13 is to offer a precise and consistent measurement solution for various analytical and research tasks.

Automatically generated - may contain errors

11 protocols using skyra vd13

1

High-field 3T Functional MRI Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI data were acquired on a 3‐Tesla Skyra VD13 (Siemens, Erlangen, Germany) with an ellipse‐shaped intraoperative 8 channels head coil (NORAS MRI products, Hochberg, Germany). Whole‐brain 2D BOLD fMRI EPI (Mansfield 1977) sequence planned axially on the anterior commissure—posterior commissure (ACPC) line plus 20° on a sagittal image with voxel size: 3 × 3 × 3 mm3, acquisition of matrix 64 × 64, 35 slices with ascending acquisition, slice gap 0.3 mm, GRAPPA factor 2 with 32 ref. lines, adaptive Coil Combination, Auto Coil Selection, Repetition Time (TR)/TE 2000/30 ms, flip angle 85° (optimized for gray matter), bandwidth 2368 Hz/Px, 220 volumes, Field of View 192 × 192 mm. Furthermore, a 3D T1‐weighted MPRAge image was also planned on the ACPC line on a sagittal image with recon voxel size: 0.47 × 0.47 × 0.9 mm3, acquisition of matrix 256 × 256, 192 slices, slice oversampling 25%, GRAPPA factor 2 with 24 ref. lines, adaptive Coil Combination, TR/TE/TI 1900/2.60/900 ms, flip angle 9°, bandwidth 220 Hz/Px, Field of View 240 × 240 mm. The T1‐image was acquired for coregistration, skull stripping, and overlay purposes.
+ Open protocol
+ Expand
2

Neuroanatomical Profiling of Brain Tumors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Topographic tumour profiles were obtained from a previously published and openly available single-centre cohort of n = 1000 consecutive patients with newly diagnosed brain tumours (https://doi.org/10.5281/zenodo.5457402).9 The eligibility criteria comprised (i) first diagnosis with consecutive histopathologic confirmation of a neuroepithelial tumour or brain metastases; (ii) no pretreatment or previous cranial surgery; (iii) intraparenchymal encephalic tumour location; (iv) availability of preoperative MRI data. For a detailed description of the acquired demographic (sex, age), clinical (Karnofsky Performance Status, type of surgery, chemotherapy, radiotherapy), radiological (presurgical 3-tesla Skyra VD13 MRI, Siemens Healthcare, Erlangen, Germany, with a 24- or 32-channel receive coil) and histopathological (histological and molecular characterization of MIB-1, 1p19q, IDH, MGMT promoter methylation) data, we refer to the protocol of the original cohort paper.9 Each patient’s topographic tumour profile was based on a standardized whole-brain parcellation protocol21 and contained 120 anatomical annotations. We excluded 44 patients with primary central nervous system lymphoma and 20 tumours with indistinct gyral patterns for the analyses in this study.
+ Open protocol
+ Expand
3

Multimodal Neuroimaging of Brain Function

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI data were acquired on a 3-T Skyra VD13 (Siemens Healthcare, Erlangen, Germany) with a 32-channel head coil. BOLD fMRI parameters and a 3-dimensional (3D) T1-weighted Magnetization Prepared Rapid Acquisition Gradient Echo (MP RAGE) image were performed. FET-PET scans were performed on an ECAT EXACT HRþ scanner (Siemens Healthcare, Erlangen, Germany).
+ Open protocol
+ Expand
4

Vascular Reactivity Assessment using BOLD MRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI data were acquired on a 3‐tesla Skyra VD13 (Siemens Healthcare, Erlangen, Germany). During the BOLD MRI sequence, the CO2 stimulus was modulated by a computer‐controlled gas blender with prospective gas targeting algorithms (RespirAct, Thornhill Research Institute, Toronto, Canada).
18 (link) Details about BOLD MRI acquisition and data processing can be found in Data S1.
The CVR calculation
19 (link) included voxel‐wise temporal shifting for optimal physiological correlation of the BOLD signal and CO2 time series. CVR, defined as the percentage BOLD signal change/mm Hg CO2, was then calculated from the slope of a linear least square fit of the BOLD signal time course to the CO2 time series over the range of the first baseline of 100 seconds, the step portion of the protocol (80 seconds) and the second baseline of 100 seconds on a voxel‐by‐voxel basis.
19 (link),
20 (link)
+ Open protocol
+ Expand
5

High-Resolution T1-Weighted Brain MRI Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All subjects underwent the same imaging protocol. A 3-T Skyra VD13 (Siemens Healthcare, Erlangen, Germany) with a 32-channel receive coil was used for MRI data acquisition. An anatomical three-dimensional high-resolution T1-weighted Magnetization Prepared Rapid Acquisition Gradient Echo (MPRAGE) image was acquired with the following specification (van Niftrik et al. 2018 (link)): ACPC line plus 20° (on a sagittal image), voxel size 0.8 × 0.8 × 1.0 mm3, field of view 230 × 230 × 176 mm3, scan matrix of 288 × 288 × 176, TR/TE/TI 2200/5.14/900 ms, flip angle 8°.
+ Open protocol
+ Expand
6

Measuring Cerebrovascular Reactivity with fMRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
MRI data were acquired on a 3-tesla Skyra VD13 scanner (Siemens Healthineers, Forchheim, Germany) with a 32-channel head coil. BOLD fMRI parameters and a three-dimensional (3 D) T1-weighted Magnetization Prepared Rapid Acquisition Gradient Echo (MP RAGE) image was performed in the same way as published in our previous work.13 (link)
During the BOLD fMRI sequence, the carbon dioxide (CO2) stimulus was given with a computer controlled gas blender with prospective gas targeting algorithms (RespirAct™, Thornhill Research Institute, Toronto, Canada). The RespirAct™ allows for precise targeting of arterial partial pressure CO2 while maintaining normal levels of O2 (iso-oxia).16 (link)
During the CVR study, a standardized and controlled hypercapnic stimulus is applied (i.e. the patients´ CO2 was increased ∼10 mmHg above their resting CO2 value for 80 seconds).13 (link)
All the acquired raw BOLD fMRI volumes were transferred to an external computer and pre-processed with SPM 12 (Statistical Parameter Mapping Software, Wellcome Department of Imaging Neuroscience, University College of London, London, UK). The BOLD fMRI volumes were processed and aligned to the T1-weighted MP RAGE image as well as smoothed with a Gaussian Kernel (for more information, see Sebök et al., 2018, Methods).13 (link)
+ Open protocol
+ Expand
7

Functional MRI Measurement of Cerebrovascular Reactivity

Check if the same lab product or an alternative is used in the 5 most similar protocols
BOLD functional MRI images were obtained using a 3-T Skyra VD13 (Siemens Healthcare) scanner with CO 2 as the vasoactive stimulus modulated by a computercontrolled gas blender with prospective gas-targeting algorithms (RespirAct, Thornhill Research Institute). This allowed for a short 80-second duration of iso-oxic hypercapnia to induce a vascular response. A high-resolution T1-weighted magnetization-prepared rapid acquisition gradient echo (MP-RAGE) image was obtained for anatomical overlay of the BOLD-CVR images. All BOLD-CVR images were obtained using a previously published method, 23 which has been used in multiple studies. 14, 17, 20 BOLD-CVR, defined as the percentage of the BOLD signal change/mm Hg CO 2 , was calculated from the slope of a linear least-square fit of the BOLD signal time course to the CO 2 time course during the BOLD scan. 23 From the T1-weighted MP-RAGE scan, a probability map for the gray matter, white matter, and CSF was obtained. Each T1-weighted MP-RAGE image was then manually masked for the affected hemisphere, and in combination with a gray-white matter probability map (> 80% probability), CVR of the affected hemisphere was calculated.
+ Open protocol
+ Expand
8

Stereotactic Targeting of Posterolateral STN

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stereotactic targeting of the posterolateral STN was performed using the StealthStation FrameLink planning software and Cranial 3 planning software (Medtronic, Minneapolis, Minnesota, United States) based on patient-specific cranial MRI 3D space T2 and 3D space T1 gadolinium-enhanced sequences (3-T Skyra VD13, Siemens Healthineers GmbH, Erlangen, Germany). The MR planning images were fused to a frame-based stereotactic computed tomography (CT; 1-mm slice thickness with contrast agent; SOMATOM Sensation 64, after June 2016 SOMATOM Definition AS, Siemens Healthineers GmbH, Erlangen, Germany) on the day of surgery. The PSP was regularly defined as 2 mm inferior of the electrophysiologically identified STN entry point. Immediately after lead insertion, a native CT with the stereotactic frame was performed and fused to the initial planning CT. The Euclidian distance between the intended (including intraoperative adjustment) and the actual lead trajectory was calculated for anteroposterior (AP) and mediolateral (ML) coordinates using the center of the lead artifact in the probe's eye view to determine the actual lead. 24 The depth was regularly defined according to MER findings. If present, lateral lead aberrance of !2 mm was corrected during the same surgical session.
+ Open protocol
+ Expand
9

Multimodal Neuroimaging Protocol for BOLD fMRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
Studies were acquired on a 3 Tesla Skyra VD13 (Siemens, Erlangen, Germany) using a 32channel head coil with the following parameters: an axial 2D EPI BOLD fMRI sequence planned on the ACPC line plus 20° on a sagittal image with voxel size: 3×3×3 mm 3 , acquisition of matrix 64x64x35 slices with ascending interleaved acquisition, slice gap 0.3 mm, GRAPPA factor 2 with 32 ref. lines, Repetition Time (TR)/TE 2000/30 ms, flip angle 85°, bandwidth 2368 Hz/Px, Field of View 192x192 mm 2 . Secondly, a high resolution 3D T1weighted anatomical image was acquired with the same orientation as the fMRI scan for coregistration and overlay purposes. The acquisition parameters were: voxel size: 0.8×0.8×1.0 mm 3 with a Field of View 230x230 mm 2 and resolution of 288x288. 176 slices per slab with a thickness of 1 mm, TR/TE 2200/5.14 ms, TI 900 ms, flip angle 8°. The FLAIR images were acquired with the same orientation as the BOLD and T1-weighted images. The acquisition parameters were as followed 0.9x0.9x1.0 mm 3 with a Field of View 230x230 mm 2 and resolution of 256x256, 176 slices per slab with a thickness of 1 mm, TR/TE 4000/387 ms, TI 1800 ms.
+ Open protocol
+ Expand
10

Evaluating Pituitary Adenoma Resection via MRI

Check if the same lab product or an alternative is used in the 5 most similar protocols
We defined GTR at 3 months as our primary endpoint. Patients underwent preoperative and 3-month postoperative volumetric contrast-enhanced MRI (3-T Skyra VD13, Siemens) at a field strength of 3 T. Rating was performed by a board-certified neurosurgeon with extensive experience in pituitary surgery and imaging. Adenoma morphology was graded according to the modified Knosp 14 and Hardy 9 classifications. Each adenoma was also manually contoured on source volumetric sequences to allow subsequent 3D rendering and volumetric measurement through the software (iPlan Cranial, Brainlab). Extent of resection (EOR) was measured on 3-month postoperative MRI and was calculated as the percentagewise reduction of residual tumor volume to baseline tumor volume on preoperative MRI. An EOR of 100% corresponded to GTR. The smallest distance between the 2 horizontal C 4 segments of the internal carotid arteries was defined as the intercarotid distance (ICD), and tumor diameters in 3 axes were obtained on coronal sections. 3, 21
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!